Mark Schoenberg, Chief Medical Officer at UroGen Pharma Ltd. (URGN), sold 3,789 shares at $15.74 ($60K) on 2024-01-31, disclosed to the SEC on 2024-02-02.
Seasonal sale ($60k) by Chief Medical Officer — this insider has traded URGN in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.74 | 758 | $12K | 20.0% |
| 2 | $15.74 | 1,137 | $18K | 30.0% |
| 3 | $15.74 | 1,894 | $30K | 50.0% |
| Total | $15.74 avg | 3,789 | $60K | 100% |
| Filing → |
| URGN | SELL | 2026-07-10 | $400K | — | Filing → |
| URGN | SELL | 2026-06-24 | $350K | — | Filing → |
| URGN | SELL | 2026-06-09 | $143K | — | Filing → |